101
Views
31
CrossRef citations to date
0
Altmetric
Original Article

Structural and Functional Characterization of Hla-Dr Molecules Circulating in the Serum

, &
Pages 289-296 | Received 10 Apr 1990, Accepted 02 Aug 1990, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Renee F. Conway, Kevin M. Okarski & John A. Szivek. (2019) A Purification Technique for Adipose-Derived Stromal Cell Cultures Leads to a More Regenerative Cell Population. Journal of Investigative Surgery 32:5, pages 381-392.
Read now
M. Hagihara, K. Hosoi, T. Kagawa, B. Gansuvd, B. Munkhbat, T. Shimura, N. Watanabe, S. Matsuzaki & Kimiyoshi Tsuj. (1999) Serum Soluble HLA-DR Antigens in Autoimmune Hepatitis. Autoimmunity 31:2, pages 85-93.
Read now

Articles from other publishers (29)

Raj S. Patel & Babita Agrawal. (2023) Mucosal immunization with lipopeptides derived from conserved regions of SARS-CoV-2 antigens induce robust cellular and cross-variant humoral immune responses in mice. Frontiers in Immunology 14.
Crossref
Nelson K. Y. Wong, Xin Dong, Yen-Yi Lin, Hui Xue, Rebecca Wu, Dong Lin, Colin Collins & Yuzhuo Wang. (2022) Framework of Intrinsic Immune Landscape of Dormant Prostate Cancer. Cells 11:9, pages 1550.
Crossref
Ananya Das, Sraddhya Roy, Snehasikta Swarnakar & Nabanita Chatterjee. (2021) Understanding the immunological aspects of SARS-CoV-2 causing COVID-19 pandemic: A therapeutic approach. Clinical Immunology 231, pages 108804.
Crossref
Amy L. Kessler, Marco J. Bruno & Sonja I. Buschow. (2020) The Potential of Soluble Human Leukocyte Antigen Molecules for Early Cancer Detection and Therapeutic Vaccine Design. Vaccines 8:4, pages 775.
Crossref
Jonathan Visentin, Lionel Couzi, Claire Dromer, Martine Neau-Cransac, Gwendaline Guidicelli, Vincent Veniard, Karine Nubret-le Coniat, Pierre Merville, Carmelo Di Primo & Jean-Luc Taupin. (2018) Overcoming non-specific binding to measure the active concentration and kinetics of serum anti-HLA antibodies by surface plasmon resonance. Biosensors and Bioelectronics 117, pages 191-200.
Crossref
Mohammad Javad Ebrahimi, Abbas Aliaghaei, Mahdi Eskandarian Boroujeni, Fariba Khodagholi, Gholamhoussein Meftahi, Mohammad Amin Abdollahifar, Houssein Ahmadi, Samira Danyali, Mahtab Daftari & Yousef Sadeghi. (2018) Human Umbilical Cord Matrix Stem Cells Reverse Oxidative Stress-Induced Cell Death and Ameliorate Motor Function and Striatal Atrophy in Rat Model of Huntington Disease. Neurotoxicity Research 34:2, pages 273-284.
Crossref
Danilo Ritz, Emiliano Sani, Hanna Debiec, Pierre Ronco, Dario Neri & Tim Fugmann. (2018) Membranal and Blood-Soluble HLA Class II Peptidome Analyses Using Data-Dependent and Independent Acquisition. PROTEOMICS 18:12, pages 1700246.
Crossref
Katerina Bakela & Irene Athanassakis. (2018) Soluble major histocompatibility complex molecules in immune regulation: highlighting class II antigens. Immunology 153:3, pages 315-324.
Crossref
Johanna Tolva, Riitta Paakkanen, Hanna Jarva, Pirkko Pussinen, Aki S. Havulinna, Veikko Salomaa, Juha Sinisalo & Marja-Liisa Lokki. (2017) Soluble HLA-DR serum levels are associated with smoking but not with acute coronary syndrome. Atherosclerosis 266, pages 58-63.
Crossref
. 2016. Leong's Manual of Diagnostic Antibodies for Immunohistology. Leong's Manual of Diagnostic Antibodies for Immunohistology 265 266 .
Katerina Bakela, Nikos Kountourakis, Michalis Aivaliotis & Irene Athanassakis. (2015) Soluble MHC-II proteins promote suppressive activity in CD4 + T cells . Immunology 144:1, pages 158-169.
Crossref
William B. Tabayoyong & Nicholas Zavazava. (2007) Soluble HLA revisited. Leukemia Research 31:2, pages 121-125.
Crossref
M.W. Hayman, M.T.A. van Beijnen, L.K. Stamp, M.B. Spellerberg & J.L. O'Donnell. (2006) Soluble human leukocyte antigen: A diagnostic indicator of rheumatoid arthritis?. Journal of Immunological Methods 315:1-2, pages 19-26.
Crossref
Irena Adamashvili, Alireza Minagar, Eduardo Gonzalez-Toledo, Liubov Featherston & Roger E Kelley. (2005) Soluble HLA measurement in saliva and cerebrospinal fluid in Caucasian patients with multiple sclerosis: a preliminary study. Journal of Neuroinflammation 2:1.
Crossref
Irena Adamashvili, Roger E. Kelley, Thomas Pressly & John C. McDonald. (2005) Soluble HLA: patterns of expression in normal subjects, autoimmune diseases, and transplant recipients. Rheumatology International 25:7, pages 491-500.
Crossref
ALIREZA MINAGAR, IRENA ADAMASHVILLI, STEPHEN L. JAFFE, MICHAEL F. GLABUS, EDUARDO GONZALEZ-TOLEDO & ROGER E. KELLEY. (2005) Soluble HLA Class I and Class II Molecules in Relapsing-Remitting Multiple Sclerosis: Acute Response to Interferon-β1a Treatment and Their Use as Markers of Disease Activity. Annals of the New York Academy of Sciences 1051:1, pages 111-120.
Crossref
Balgansuren Gansuvd, Masao Hagihara, Ayako Higuchi, Yoko Ueda, Kei Tazume, Takahide Tsuchiya, Namid Munkhtuvshin, Shunichi Kato & Tomomitsu Hotta. (2003) Umbilical cord blood dendritic cells are a rich source of soluble HLA-DR: synergistic effect of exosomes and dendritic cells on autologous or allogeneic T-Cell proliferation. Human Immunology 64:4, pages 427-439.
Crossref
I Athanassakis & S Vassiliadis. (2002) T-regulatory cells: are we re-discovering T suppressors?. Immunology Letters 84:3, pages 179-183.
Crossref
Vera Rebmann, Selma Ugurel, Wolfgang Tilgen, Uwe Reinhold & Hans Grosse-Wilde. (2002) Soluble HLA-DR is a potent predictive indicator of disease progression in serum from early-stage melanoma patients. International Journal of Cancer 100:5, pages 580-585.
Crossref
Renate Claus, Thomas Bittorf, Hermann Walzel, Josef Brock, Robert Uhde, Doris Meiske, Ulrich Schulz, Dirk Hobusch, Karin Schumacher, Mathias Witt, Frank Bartel & Stefan Hausmann. (2000) High Concentration of Soluble HLA-DR in the Synovial Fluid: Generation and Significance in “Rheumatoid-like” Inflammatory Joint Diseases. Cellular Immunology 206:2, pages 85-100.
Crossref
Irene Athanassakis, Anthi Ranella & Simon Vassiliadis. (2000) IFN-γ Facilitates Release of Class II-Loaded Intracellular Pools in Trophoblast Cells: A Novel Property Independent of Protein Synthesis. Journal of Interferon & Cytokine Research 20:9, pages 823-830.
Crossref
Donnie Aultman, Irena Adamashvili, Kamalakar Yaturu, Marlyn Langford, Frank Gelder, Michael Gautreaux, G.E Ghali & John McDonald. (1999) Soluble HLA in human body fluids. Human Immunology 60:3, pages 239-244.
Crossref
Robert E. Wolf, Irena M. Adamashvili, Frank B. Gelder, Vicky C. Hall, Patricia A. Fraser & John C. McDonald. (1998) Soluble HLA-I in rheumatic diseases. Human Immunology 59:10, pages 644-649.
Crossref
Edward G. Spack, Nancy G. Wehner & Jeffrey L. Winkelhake. (2006) Preclinical and Pharmacological Studies of AG284, a Soluble HLA‐DR2:Myelin Basic Protein Peptide Complex for the Treatment of Multiple Sclerosis. CNS Drug Reviews 4:3, pages 225-246.
Crossref
John C. McDonald & Irena Adamashvili. (1998) Soluble HLA:. Human Immunology 59:7, pages 387-403.
Crossref
G.P. Russwurm, A.M. Mackler, O.R. Fagoaga, W.S. BrownIIIIII, E.P. Sakala, S.M. Yellon & S.L. Nehlsen‐Cannarella. (2011) Soluble Human Leukocyte Antigens, Interleukin‐6, and Interferon‐γ During Pregnancy. American Journal of Reproductive Immunology 38:4, pages 256-262.
Crossref
John C. McDonald, Irina Adamashvili, Gazi B. Zibari, Donnie F. Aultman, Mary C. Mancini, Robert W. McMillan & Frank B. Gelder. (1997) SEROLOGIC ALLOGENEIC CHIMERISM. Transplantation 64:6, pages 865-871.
Crossref
V. Rebmann, K. Dornmair & H. Grosse‐Wilde. (2008) Biochemical analysis of plasma‐soluble invariant chains and their complex formation with soluble HLA‐DR. Tissue Antigens 49:5, pages 438-442.
Crossref
DAVID G. HICKS, ALEXANDER R. JUDKINS, JOSHUA Z. SICKEL, RANDY N. ROSIER, J. EDWARD PUZAS & REGIS J. OʼKEEFE. (1996) Granular Histiocytosis of Pelvic Lymph Nodes following Total Hip Arthroplasty. The Presence of Wear Debris, Cytokine Production, and Immunologically Activated Macrophages*. The Journal of Bone & Joint Surgery 78:4, pages 482-96.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.